September 17, 2015 – The FDA (Food and Drug Administration) Pediatric Advisory Committee (PAC) advises and makes recommendations to the Commissioner of Food and Drugs regarding a range of issues related to prescription drugs intended for use in the pediatric population. A panel of doctors and other medical specialists sit on this panel, with appropriate […]
Archive for September, 2015
September 14, 2015 – Sideris Pharmaceuticals has announced that it has terminated its SP-420 development program. This Phase 1 study, entitled “Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia” (ClinicalTrials.gov identifier NCT02274233), was assessing safety and amount of the study drug in the blood after increasing doses […]
September 14, 2015 – The FDA (Food and Drug Administration) Office of Minority Health is holding a special webinar on Tuesday, September 29, entitled “Get to Know ClinicalTrials.Gov.” The webinar, which will run from 11:00 a.m. – 12:00 noon (EDT) is intended to explain what a person can expect to find on ClinicalTrials.gov and how […]
September 3, 2015 – Novartis is no longer supplying Desferal in the 2 gram doses; it is still continuing to supply Desferal in 500 mg doses. Please check with your doctor, as your prescription may need to be altered to indicate that 500 mg doses should be used.
September 1, 2015 – Join the Suffolk chapter of CAF for an evening of “Painting Under the Stars” on Tuesday, September 22. Come to Schafer’s Restaurant (111 W. Broadway in Port Jefferson, across from Port Jeff Harbor) for the 7:00 event. For an economical $35 donation, you receive instruction and painting materials to create a […]